Patient guide: what clinical trials are
This page is for people looking for a clinical trial for themselves or a loved one for the first time. Plain words, no promises, no pressure.
What a clinical trial is
It is a scientific study of a new treatment (a drug, cell therapy, or procedure) involving patients. Before a new method is approved for everyone, its efficacy and safety are tested in such studies. For a patient who has exhausted standard options, a trial can be a way to access a new therapy earlier than it becomes generally available.
Important: a trial is a chance, not a guarantee. The method is being studied precisely because its efficacy is still being proven.
Is it safe?
Every trial passes ethics review, and participants are continuously monitored by physicians. New methods can still have previously unknown side effects — the risks must be explained to you before you sign informed consent, and you may leave a trial at any time.
The word "phase" describes the testing stage: Phase I — first safety assessment in a small group; Phase II — efficacy assessment; Phase III — comparison with the best existing treatment in a large group; Phase IV — observation after approval.
What it costs
In many studies, the sponsor pays for the investigational treatment and trial-related procedures. The registry does not show exactly which costs are covered, however: travel, accommodation, regular medical care, and tests outside the protocol may be separate. Ask the study center to confirm every cost in writing. Lechu coordinator services are free for patients.
What to ask about costs, travel, and documents →
Will I get a placebo instead of treatment?
In oncology and hematology a "sugar pill" instead of treatment is almost never used: new methods are usually compared with the best available standard treatment. If a trial uses a placebo, this is always stated in the protocol, and you must be told before consenting.
Who decides whether I qualify?
Every trial has inclusion and exclusion criteria (diagnosis, age, prior treatment, lab values). The final decision is made by the study center physician after reviewing your medical documents — neither this site nor a coordinator can assess eligibility.
How to read a trial page
- NCT number
- The trial's unique number in the government registry ClinicalTrials.gov. Any doctor can find the full protocol by it.
- Status
- "Recruiting" — patients are being accepted now. "Not yet recruiting" — approved, enrollment not open yet. "By invitation" — participants are chosen by the investigators.
- Eligibility criteria
- Inclusion (who can join) and exclusion (who cannot) conditions, quoted verbatim from the protocol in English.
- Sponsor
- The organization running the study — a hospital, university or pharmaceutical company.
- Outcome measures
- What exactly the researchers measure to understand whether the method works (e.g. survival or tumor response).
- Planned enrollment
- How many participants the study intends to include.
Questions worth asking the doctor
- What is the goal of this trial and what is already known about the method?
- How would participation differ from standard treatment in my case?
- What side effects have been observed and how are they managed?
- What happens if the method does not help or I want to leave?
- Which costs will fall on me and my family?